As American cardiologists redraw the boundaries of cholesterol management with tighter LDL targets and a longer view of lifetime risk, India pauses at the threshold—not to reject the new map, but to ask whether it was drawn for a different country. The ICMR-INDIAB study, surveying over 121,000 adults, revealed that nearly nine in ten Indians carry some form of lipid abnormality, often silently and a decade before Western populations show similar patterns. India's specialists see in the American guideline a philosophical kinship—early detection, lifetime risk, treatment beyond a single number—b
New US cholesterol targets offer India a reference, not a template
Cardiovascular disease develops roughly a decade earlier in Indians, affecting millions with undetected lipid abnormalities and increasing premature mortality risk.